Sydney-based Pharmaxis(ASX:PXS) has announced it is progressing the development of an oral anti‐fibrotic Lysyl Oxidase (LOX) inhibitor for the treatment of myelofibrosis and pancreatic cancer. …
Latest Video
New Stories
-
Roche welcomes new partnership with government
January 30, 2020 - - Latest News -
MA responds on transparency in the decision-making process
January 30, 2020 - - Latest News -
'Consider the opportunity, not just the cost'
January 30, 2020 - - Latest News -
Didier Dargent: The era of disruption has arrived
January 30, 2020 - - Latest News -
Melissa McGregor leaves a lasting legacy
January 30, 2020 - - Latest News -
Roche teams up with federal government on genome project
January 30, 2020 - - Latest News -
Gilead announces first grants under new HIV program
January 29, 2020 - - Latest News